This paper appears in the following:
- St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
- An Oligomer Test for PD—Could One for AD Be Close Behind?
- Common Ground: Is Aβ the Foundation for Multiple Dementias?
- Still Early Days for α-synuclein Fluid Marker
- In Healthy Brains, Does Aβ Really Matter?
- Triple Confirmation: AD Footprint in CSF of Cognitively Normal People
- Alzheimer Activism: How To Modernize Clinical Trials?
- Research Brief: More Evidence That CSF Aβ Changes Precede AD
- CSF Biomarkers Track With Atrophy, Cognition in Normal Aging
- More ADNI Results 2: It’s All About Power
- Sweet 16: Novel APP Processing Pathway and a New Biomarker?
- Subjective Memory Complaint—Not So Subjective Anymore?
- Tau Biomarkers—More Informative Fragments in Spinal Fluid?
- At AAIC, Researchers Debate Neurogranin's Measure as a Marker